Performant Healthcare Inc financial data

Symbol
PHLT on Nasdaq
Location
900 South Pine Island Road, Suite 150, Plantation, FL
State of incorporation
DE
Fiscal year end
December 31
Former names
Performant Financial Corp (to 11/15/2024)
Latest financial report
10-K - Q4 2024 - Mar 13, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 270 % -22.1%
Debt-to-equity 32.8 % +21.3%
Return On Equity -13 % -37.1%
Return On Assets -9.77 % -31.2%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 78.3M shares +1.81%
Common Stock, Shares, Outstanding 78.3M shares +1.81%
Entity Public Float 128M USD +6.78%
Common Stock, Value, Issued 8K USD 0%
Weighted Average Number of Shares Outstanding, Basic 77.5M shares +1.77%
Weighted Average Number of Shares Outstanding, Diluted 77.5M shares +1.77%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 123M USD +8.12%
Operating Income (Loss) -9.5M USD -55%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -10.2M USD -30.4%
Income Tax Expense (Benefit) -351K USD -3.24%
Net Income (Loss) Attributable to Parent -9.9M USD -31.6%
Earnings Per Share, Basic -0.13 USD/shares -30%
Earnings Per Share, Diluted -0.13 USD/shares -30%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 9.29M USD +28.1%
Accounts Receivable, after Allowance for Credit Loss, Current 14.2M USD -19.4%
Assets, Current 38.4M USD -3.58%
Property, Plant and Equipment, Net 14M USD +44.2%
Operating Lease, Right-of-Use Asset 826K USD +55.6%
Goodwill 47.4M USD 0%
Other Assets, Noncurrent 781K USD -21.1%
Assets 102M USD +2.77%
Accounts Payable, Current 482K USD -33.7%
Employee-related Liabilities, Current 8.5M USD +7.29%
Accrued Liabilities, Current 2M USD -4.76%
Contract with Customer, Liability, Current 753K USD +52.7%
Liabilities, Current 14M USD +12.9%
Operating Lease, Liability, Noncurrent 462K USD +56.6%
Other Liabilities, Noncurrent 156K USD -75.9%
Liabilities 25.3M USD +37.9%
Retained Earnings (Accumulated Deficit) -75.2M USD -15.2%
Stockholders' Equity Attributable to Parent 76.5M USD -5.21%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 76.5M USD -5.21%
Liabilities and Equity 102M USD +2.77%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 121K USD
Net Cash Provided by (Used in) Financing Activities -14K USD +99.8%
Net Cash Provided by (Used in) Investing Activities -3.65M USD -303%
Common Stock, Shares Authorized 500M shares 0%
Common Stock, Shares, Issued 78.3M shares +1.81%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -3.55M USD +67.9%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 9.29M USD +26.7%
Interest Paid, Excluding Capitalized Interest, Operating Activities 127K USD -78.2%
Deferred Tax Assets, Valuation Allowance 15.8M USD +36.4%
Deferred Tax Assets, Gross 16.6M USD +35.4%
Operating Lease, Liability 845K USD +55%
Payments to Acquire Property, Plant, and Equipment 3.65M USD +302%
Lessee, Operating Lease, Liability, to be Paid 932K USD +56.9%
Property, Plant and Equipment, Gross 61.9M USD -16.7%
Operating Lease, Liability, Current 383K USD +53.2%
Lessee, Operating Lease, Liability, to be Paid, Year Two 240K USD +66.7%
Lessee, Operating Lease, Liability, to be Paid, Year One 428K USD +56.8%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure +17.5%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 87K USD +77.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three 158K USD +139%
Deferred Tax Assets, Operating Loss Carryforwards 9.15M USD +27.6%
Unrecognized Tax Benefits 7K USD -97.8%
Lessee, Operating Lease, Liability, to be Paid, Year Four 106K USD +76.7%
Operating Lease, Payments 100K USD -50%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 6.6M USD +27.2%
Deferred Tax Assets, Net of Valuation Allowance 805K USD +18.4%
Share-based Payment Arrangement, Expense 5.9M USD +51.3%
Interest Expense 1.75M USD +37.9%